StockData
BioCardia, Inc. logo

BioCardia, Inc. (BCDA) stock

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.79−0.00 (-0.24%)

Close on Nov 17, 2026Market cap $11.93MP/E –Yield –

BioCardia net income

Net income is the profit left for shareholders after every expense, interest and tax.

BioCardia's net income for the twelve months ending Jun 30, 2026 was -$7.34M. For fiscal 2025 it was -$8.23M. The highest annual figure on record is $9.66M in fiscal 2011.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.23M–
FY2024Dec 31, 2024-$7.95M–
FY2023Dec 31, 2023-$11.57M–
FY2022Dec 31, 2022-$11.91M–
FY2021Dec 31, 2021-$12.62M–
FY2020Dec 31, 2020-$15.00M–
FY2019Dec 31, 2019-$14.71M–
FY2018Dec 31, 2018-$13.99M–
FY2017Dec 31, 2017-$12.31M–
FY2016Dec 31, 2016-$10.31M–
FY2015Dec 31, 2015-$6.70M-2962.0%
FY2014Dec 31, 2014$234.00K+1131.6%
FY2013Dec 31, 2013$19.00K-93.8%
FY2012Dec 31, 2012$305.00K-96.8%
FY2011Dec 31, 2011$9.66M–
FY2010Dec 31, 2010-$11.51M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.61M–
Q1 FY2026Mar 31, 2026-$2.26M–
Q4 FY2025Dec 31, 2025-$1.98M–
Q3 FY2025Sep 30, 2025-$1.48M–
Q2 FY2025Jun 30, 2025-$2.05M–
Q1 FY2025Mar 31, 2025-$2.71M–
Q4 FY2024Dec 31, 2024-$2.30M–
Q3 FY2024Sep 30, 2024-$1.74M–
Q2 FY2024Jun 30, 2024-$1.65M–
Q1 FY2024Mar 31, 2024-$2.27M–
Q4 FY2023Dec 31, 2023-$2.07M–
Q3 FY2023Sep 30, 2023-$2.57M–
Q2 FY2023Jun 30, 2023-$3.42M–
Q1 FY2023Mar 31, 2023-$3.50M–
Q4 FY2022Dec 31, 2022-$3.03M–
Q3 FY2022Sep 30, 2022-$3.06M–
Q2 FY2022Jun 30, 2022-$2.50M–
Q1 FY2022Mar 31, 2022-$3.33M–
Q4 FY2021Dec 31, 2021-$3.46M–
Q3 FY2021Sep 30, 2021-$2.71M–
Q2 FY2021Jun 30, 2021-$3.49M–
Q1 FY2021Mar 31, 2021-$2.97M–
Q4 FY2020Dec 31, 2020-$2.99M–
Q3 FY2020Sep 30, 2020-$3.85M–
Q2 FY2020Jun 30, 2020-$3.57M–
Q1 FY2020Mar 31, 2020-$4.59M–
Q4 FY2019Dec 31, 2019-$3.50M–
Q3 FY2019Sep 30, 2019-$3.79M–
Q2 FY2019Jun 30, 2019-$3.75M–
Q1 FY2019Mar 31, 2019-$3.67M–
Q4 FY2018Dec 31, 2018-$3.64M–
Q3 FY2018Sep 30, 2018-$3.54M–
Q2 FY2018Jun 30, 2018-$3.22M–
Q1 FY2018Mar 31, 2018-$3.58M–
Q4 FY2017Dec 31, 2017-$3.49M–
Q3 FY2017Sep 30, 2017-$3.00M–
Q2 FY2017Jun 30, 2017-$2.95M–
Q1 FY2017Mar 31, 2017-$2.88M–
Q4 FY2016Dec 31, 2016-$3.58M–
Q3 FY2016Sep 30, 2016-$3.25M–

More BioCardia figures

See a number that looks wrong?